secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001654954-23-008484
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech appoints Stephen Lemieux as CFO effective July 15, 2023
---------------------------------------------------------------------

- Stephen Lemieux, CPA, appointed CFO; base salary $330K USD plus 40% target annual bonus.
- Lemieux brings 20+ yrs experience; previously CFO at Titan Medical and Cipher Pharmaceuticals.
- Employment agreement includes severance of 12-24 months salary and change-of-control protections.
- CFO will also receive $2K monthly auto allowance and eligibility for equity awards.
- Lemieux currently provides financial advisory to Edesa; appointment builds on regulatory progress.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423008484/0001654954-23-008484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495423008484/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-008484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer